duofilm 167 mg/150 mg/g uz ādas lietojams šķīdums
stada arzneimittel ag, germany - skābes salicylicum, skābes lacticum - uz ādas lietojams šķīdums - 167 mg/150 mg/g
venclyxto
abbvie deutschland gmbh co. kg - venetoklakss - leikēmija, limfocītu, hroniska, b-šūna - antineoplastiski līdzekļi - venclyxto in combination with obinutuzumab is indicated for the treatment of adult patients with previously untreated chronic lymphocytic leukaemia (cll) (see section 5. venclyxto in combination with rituximab is indicated for the treatment of adult patients with cll who have received at least one prior therapy. venclyxto monotherapy is indicated for the treatment of cll:- in the presence of 17p deletion or tp53 mutation in adult patients who are unsuitable for or have failed a b cell receptor pathway inhibitor, or- in the absence of 17p deletion or tp53 mutation in adult patients who have failed both chemoimmunotherapy and a b-cell receptor pathway inhibitor. venclyxto in combination with a hypomethylating agent is indicated for the treatment of adult patients with newly diagnosed acute myeloid leukaemia (aml) who are ineligible for intensive chemotherapy.
mirvaso
galderma international - brimonidīna tartrāts - Ādas slimības - citi dermatoloģiski preparāti - mirvaso ir indicēts rosacea sejas erythema simptomātiskai ārstēšanai pieaugušiem pacientiem.
fucicort 20 mg/1 mg/g krēms
leo pharma a/s, denmark - skābes fusidicum, betamethasoni valeras - krēms - 20 mg/1 mg/g
fucidin 20 mg/g ziede
leo pharma a/s, denmark - nātrija fuzidāts - ziede - 20 mg/g
pantoprazole actavis 20 mg zarnās šķīstošās tabletes
teva b.v., netherlands - pantoprazols - zarnās šķīstošā tablete - 20 mg
pantoprazole actavis 40 mg zarnās šķīstošās tabletes
teva b.v., netherlands - pantoprazols - zarnās šķīstošā tablete - 40 mg
Ūdeņraža peroksīds rff 3% šķīdums
rīgas farmaceitiskā fabrika, a/s, latvia - ūadeņražea peroksīds - uz ādas lietojams šķīdums - 30 mg/ml
tibsovo
les laboratoires servier - ivosidenib - leukemia, myeloid, acute; cholangiocarcinoma - antineoplastiski līdzekļi - tibsovo in combination with azacitidine is indicated for the treatment of adult patients with newly diagnosed acute myeloid leukaemia (aml) with an isocitrate dehydrogenase-1 (idh1) r132 mutation who are not eligible to receive standard induction chemotherapy (see section 5. tibsovo monotherapy is indicated for the treatment of adult patients with locally advanced or metastatic cholangiocarcinoma with an idh1 r132 mutation who were previously treated by at least one prior line of systemic therapy.
qutenza
grunenthal gmbh - capsaicin - neiralģija - anestēzijas līdzekļi - qutenza ir indicēts perifēro neiropātisku sāpju ārstēšanai pieaugušajiem vai nu atsevišķi, vai kombinācijā ar citām zālēm sāpēm.